Fortrea Holdings Inc. (FTRE) vs Recursion Pharmaceuticals, Inc. (RXRX)
- Fortrea Holdings Inc. FTRE 22.49 −1.14%
- Recursion Pharmaceuticals, Inc. RXRX 3.47 −16.59%
Fortrea Holdings Inc. and Recursion Pharmaceuticals, Inc. are both Biotechnology companies. Fortrea Holdings Inc. and Recursion Pharmaceuticals, Inc. are of similar size ($2.2B and $2.2B). Fortrea Holdings Inc. grew revenue faster over the last twelve months: −2.09% against −15.1%. Fortrea Holdings Inc. has the higher net margin (−3.18% vs −945.9%) and the higher return on invested capital (−0.48% vs −92.2%). Across the 18 metrics below, Fortrea Holdings Inc. leads on 12 and Recursion Pharmaceuticals, Inc. on 6.
Valuation
Profitability
| Metric | FTRE | RXRX | Biotechnology median |
|---|---|---|---|
| Gross margin | 19.30% | 3.48% | 65.16% |
| Operating margin | (0.40%) | (991.72%) | 0.00% |
| Net margin | (3.18%) | (945.92%) | 0.00% |
| Free cash flow margin | 7.40% | (645.82%) | 0.00% |
| Return on equity | (15.30%) | (56.58%) | (56.36%) |
| Return on assets | (3.07%) | (41.26%) | (48.04%) |
| Return on invested capital | (0.48%) | (92.22%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack